Advanced glycation endproducts, dityrosine and arginine transporter dysfunction in autism – a source of biomarkers for clinical diagnosis

https://molecularautism.biomedcentral.com/articles/10.1186/s13229-017-0183-3

Further clinical validation of plasma protein CML, CMA, DT, and 3DG-H may provide improved diagnosis of ASD.

esami-sangue

Você também pode gostar